Pramipexole Dihydrochloride
Who holds supplier records for Pramipexole Dihydrochloride? 23 organisations hold a current record for Pramipexole Dihydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (14), Malta (1), Germany (1), Spain (1) and 5 other countries (5); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Pramipexole Dihydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pramipexole-dihydrochloride
Reading the evidence
- 23 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
14 of the 22 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 18 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (23)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Pramipexole Dihydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 18836 · latest filing Oct 2005
- Amino Chemicals LtdMaltaCEP Company GMP cert on recordActive DMF 18297 · latest filing Apr 2005
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 22789 · latest filing May 2009
- BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGGermanyCEP Company GMP cert on recordActive DMF 21413 · latest filing Mar 2008
- CURIA SPAIN SAUSpainCEP Company GMP cert on recordActive DMF 21791 · latest filing Jul 2008
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 19853 · latest filing Oct 2006
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 21712 · latest filing May 2008
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 23900 · latest filing Jun 2010
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 25907 · latest filing Mar 2012
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 23163 · latest filing Oct 2009
- OLON SPAItaly Company GMP cert on recordActive DMF 21082 · latest filing Nov 2007
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 22860 · latest filing Aug 2009
- PH HEALTH LTDActive DMF 22209 · latest filing Nov 2008
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 21899 · latest filing Oct 2008
- Torrent PharmaceuticalsIndia Company GMP cert on recordActive DMF 21631 · latest filing May 2008
- WAVELENGTH ENTERPRISES LTDIsrael Company GMP cert on recordActive DMF 20116 · latest filing Jan 2007
- Wockhardt LimitedIndia Company GMP cert on recordActive DMF 24781 · latest filing Jun 2011
- YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChinaActive DMF 41291 · latest filing Feb 2025
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 20130 · latest filing Jan 2007
- Apotex Pharmachem India Pvt. Ltd.IndiaCEPInactive DMF 21095 · latest filing Nov 2007
- Cipla LimitedIndiaCEP Company GMP cert on recordInactive DMF 18701 · latest filing Aug 2005
- NetherlandsCEP Company GMP cert on record
- CHR. OLESEN SYNTHESIS A/S HvidovreDenmarkCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (13)
Certificates of Suitability on the EDQM register for Pramipexole Dihydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 18 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2011-038 - Rev 07 Pramipexole dihydrochloride monohydrate | Jul 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2011-190 - Rev 01 Pramipexole dihydrochloride monohydrate | Apr 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2010-328 - Rev 04 Pramipexole dihydrochloride monohydrate | Apr 2025 | — |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | CEP 2011-050 - Rev 02 Pramipexole dihydrochloride monohydrate | Mar 2025 | — |
| BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Ingelheim Am Rhein | DE | CEP 2019-186 - Rev 01 Pramipexole dihydrochloride monohydrate | Mar 2025 | Inspected Nov 2025 Germany |
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2012-193 - Rev 01 Pramipexole dihydrochloride monohydrate | Nov 2024 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2011-047 - Rev 03 Pramipexole dihydrochloride monohydrate | Jul 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2009-292 - Rev 03 Pramipexole dihydrochloride monohydrate | Nov 2023 | — |
| CURIA SPAIN S.A.U. Boecillo | ES | R1-CEP 2010-354 - Rev 01 Pramipexole dihydrochloride monohydrate | Aug 2021 | — |
| CHR. OLESEN SYNTHESIS A/S Hvidovre | DK | R1-CEP 2010-174 - Rev 01 Pramipexole dihydrochloride monohydrate | Apr 2020 | — |
| Amino Chemicals LTD. Marsa | MT | R1-CEP 2011-127 - Rev 02 Pramipexole dihydrochloride monohydrate | Sept 2018 | — |
| SYNTHON BV Nijmegen | NL | R1-CEP 2010-375 - Rev 00 Pramipexole dihydrochloride monohydrate | May 2018 | — |
| APOTEX PHARMACHEM INDIA PVT. LTD Bangalore | IN | R1-CEP 2011-112 - Rev 00 Pramipexole dihydrochloride monohydrate | Feb 2018 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Pramipexole Dihydrochloride are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Italy · Inactive DMF 24331 · filed Oct 2010
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Pramipexole Dihydrochloride is a dopamine agonist primarily used in the treatment of Parkinson's disease and restless legs syndrome. It works by stimulating dopamine receptors in the brain, thereby alleviating symptoms associated with dopamine deficiency.
Chemical identity
- IUPAC name
- (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;hydrate;dihydrochloride
- Canonical SMILES
- CCCN[C@H]1CCC2=C(C1)SC(=N2)N.O.Cl.Cl
- InChIKey
- APVQOOKHDZVJEX-QTPLPEIMSA-N
- Synonyms
- Mirapex API, daquiran, mirapex, mirapexin, oprymea, pnu-98528e, pramipexole accord, pramipexole dihydrochloride monohydrate, pramipexole hydrochloride, pramipexole hydrochloride hydrate, pramipexole hydrochloride monohydrate, pramipexole teva
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nonergot Dopamine Agonist
- Mechanism of action
- Dopamine Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Pramipexole Dihydrochloride?
23 organisations hold an active US FDA Type II Drug Master File or a CEP for Pramipexole Dihydrochloride: Alembic Pharmaceuticals Limited (India), Amino Chemicals Ltd (Malta), APITORIA PHARMA PRIVATE LTD (India), BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (Germany), CURIA SPAIN SAU (Spain), Hetero Drugs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India) and MSN Laboratories Private Limited (India), and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Pramipexole Dihydrochloride Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 18836), Amino Chemicals Ltd (DMF 18297), APITORIA PHARMA PRIVATE LTD (DMF 22789), BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (DMF 21413), CURIA SPAIN SAU (DMF 21791), Hetero Drugs Limited (DMF 19853), MATRIX PHARMACORP PRIVATE LTD (DMF 21712) and MSN Laboratories Private Limited (DMF 23900) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Pramipexole Dihydrochloride records mean?
1 organisation has only inactive Type II DMFs for Pramipexole Dihydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Pramipexole Dihydrochloride have a European Certificate of Suitability?
Yes. 13 organisations hold a valid CEP for Pramipexole Dihydrochloride on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN), HETERO DRUGS LIMITED Hyderabad (IN), MSN LABORATORIES PRIVATE LIMITED Rudraram Village (IN), BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Ingelheim Am Rhein (DE) and UNICHEM LABORATORIES LIMITED Mumbai (IN) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Pramipexole Dihydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Pramipexole Dihydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.